Pathogenesis of polycystic ovary syndrome: what is the role of obesity?

This publication has 188 references indexed in Scilit:

• Skeletal Muscle Triglycerides
  Annals of the New York Academy of Sciences, 2002
• Insulin Sensitizer, Troglitazone, Directly Inhibits Aromatase Activity in Human Ovarian Granulosa Cells
  Biochemical and Biophysical Research Communications, 2000
• Ovulatory and Metabolic Effects of d-Chiro-Inositol in the Polycystic Ovary Syndrome
  New England Journal of Medicine, 1999
• Pediatric Endocrinology Update: An Overview
  Hormone Research in Paediatrics, 1998
• Effect of Testosterone and Estradiol in a Man with Aromatase Deficiency
  New England Journal of Medicine, 1997
• Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI‐1) activity in lean women with and without the polycystic ovary syndrome
  Clinical Endocrinology, 1996
• Decreases in Ovarian Cytochrome P450c17α Activity and Serum Free Testosterone after Reduction of Insulin Secretion in Polycystic Ovary Syndrome
  New England Journal of Medicine, 1996
• Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome.
  Journal of Clinical Investigation, 1995
• Coronary Heart Disease Risk Factors in Women With Polycystic Ovary Syndrome
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
• The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women*
  Clinical Endocrinology, 1993